Grand Rounds December 2, 2022: A Randomized Controlled Trial of Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned (G. Michael Felker, MD, MHS)
Rethinking Clinical Trials
DECEMBER 6, 2022
Making lifestyle changes is difficult especially for people living with chronic diseases, where healthy behaviors could make a big difference. The TARGET-HF-DM is a pragmatic multicenter randomized controlled trial held at 6 sites in the U.S. The primary endpoint was change in mean daily step counts from baseline to 3 months.
Let's personalize your content